May 19, 2005
FDA Antiviral
Drugs Advisory Committee Meeting
1
Tipranavir NDA 21-814
Drug Interactions
Drug Interactions
Yuanchao
(Derek) Zhang, Ph.D.
Clinical Pharmacology
Reviewer
Office of
Clinical Pharmacology and Biopharmaceutics
CDER, FDA
